| 000 | 01271pam a22003254a 4500 | ||
|---|---|---|---|
| 005 | 20250930130923.0 | ||
| 008 | 100930s2008 njua b 001 0 eng | ||
| 020 |
_a9781588296467 _cRM481.08 |
||
| 039 | 9 |
_a201104211211 _bzainol _y09-30-2010 _zfida |
|
| 040 | _aUKM | ||
| 060 |
_aQV269 _b.G335 2008 9 |
||
| 090 | _aQV269.G335 2008 9 | ||
| 245 | 0 | 0 |
_aGenomics and pharmacogenomics in anticancer drug development and clinical response / _cedited by Federico Innocenti |
| 260 |
_aTotowa, NJ : _bHumana, _c2008 |
||
| 300 |
_axiv, 377 p. : _bill. ; _c27 cm. |
||
| 490 | 1 | _aCancer drug discovery and development | |
| 505 | 0 | _aGenomic experimental approaches in oncology -- Pharmacogenomics of toxicity and response of chemotherapy -- Pharmacogenomics in clinical drug development in oncology | |
| 650 | 2 | _aGenomics. | |
| 650 | 2 |
_aNeoplasms _xDrug therapy |
|
| 650 | 2 |
_aNeoplasms _xgenetics _960519 |
|
| 650 | 2 |
_aPharmacogenetics _xmethods |
|
| 700 | 1 | _aInnocenti, Federico | |
| 830 | 0 | _aCancer drug discovery and development | |
| 907 |
_a.b14807403 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV269.G335 2008 9 |
||
| 914 | _avtls003442002 | ||
| 991 | _aJabatan Farmakologi, KKL | ||
| 998 |
_ad _b2010-04-09 _cm _da _feng _gnju _y0 _z.b14807403 |
||
| 999 |
_c467467 _d467467 |
||